Tiger Pharmaceuticals issued an insider information announcement. Trading of shares of Fangda Holdings, a subsidiary of the company, was temporarily suspended from 9:00 a.m. on October 22, 2026, pending the issuance of an announcement containing insider information. The company stated that the transaction involving Fangda Holdings does not guarantee implementation, and the company will make further announcements in due course.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.